Orphan Drugs and Rare Diseases Europe 2017
15th – 16th May 2017, Berlin, Germany
The global orphan drug market totaled nearly $123 billion in 2014 and will continue to grow to reach nearly $191 billion by 2019.*
With such growth and innovation witnessed in this field now is the best time to discuss and strategize the best route to market.
Germany is Europe's largest pharma market but is recognised as having one of the toughest pricing policies in Europe. SMi’s 6th annual Orphan Drugs will discuss the controversial German pricing mechanism as well as bring together leading industry professionals to discuss the latest regulatory developments, explore how to reduce costs and learn from the latest innovations in the orphan drug landscape.
More details at; www.orphandrugs-event.com